Heparin Market 2025 opportunities illuminated by new report | Credence Research

The heparin crisis in 2008 caused by contaminated lots of unfragmented heparin imported from China led to fatal adverse events such as a rapid drop in blood pressure and death.

SANJOSE, United States - February 5, 2019 /MarketersMedia/ —

Heparin Market is estimated at US$ 7,714.0 million in 2016, is projected to reach US$ 14,853.1 million by 2025, with a CAGR of 7.21 percent between 2017 and 2025.

Market Insights
The heparin crisis in 2008 caused by contaminated lots of unfragmented heparin imported from China led to fatal adverse events such as a rapid drop in blood pressure and death. This event led to the introduction of safer and more efficient low and ultra-low molecular heparin. Still pharmacovigilance agencies have reported several serious adverse events associated with heparin that require safer heparin products for medical use. Researchers at the University of North Carolina have developed a low molecular weight heparin with the use of C5-epimerase and recombinant enzymes of O-sulfotransferase. The newly synthesized heparin will be reversed by protamine sulphate and will be cleared by liver and not by the kidneys, and thus will overcome the earlier heparin related adverse events.

Full Report Originally published @ https://www.credenceresearch.com/report/heparin-market

Rising prevalence of venous thromboembolism and good bioavailability due to longer half-life low molecular weight heparin leads the products segment. Ultra-low molecular weight heparin will lead the market during the forecast period as it has projected better results in DVT/PE induced in patients undergoing cancer chemotherapy.

Subcutaneous is the most desirable route of administration owing to excellent drug pharmacokinetic profile for heparin and is relatively cheaper. Intravenous route is used for its fast onset of action due to high plasma protein binding and is used to perform open heart surgery, blood transfusion, and kidney dialysis.

Get Sample @ https://www.credenceresearch.com/sample-request/58943

North America is the clear leader in global heparin market as a result of rising prevalence of venous thromboembolism. In United States about 33 % of the people suffering with venous thromboembolism has a recurrence within ten years. Enhanced investment in the research and development of heparin products to address the problems associated with heparin overdose has a positive effect on market growth of North America. Increasing number of venous thromboembolism encountered in patients undergoing cancer chemotherapy and supportive regulatory environment for heparin products will be responsible for the remarkable growth of Asia Pacific in global heparin market.

Market players engaged in the manufacture and sale of heparin products are Aspen Holdings, Teva Pharmaceutical Industries Ltd., Baxter International, Inc., Syntex S.A., B. Braun Melsungen AG, Sanofi AG, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., LEO Pharma A/S., and Fresenius SE & Co. KGaA among others.

Full Report Originally published @ https://www.credenceresearch.com/report/heparin-market

ToC:
Chapter 4. Global Heparin Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Heparin Market, by Product, 2016
4.3. Unfractionated Heparin
4.4. Low Molecular Weight Heparin
4.5. Ultra-Low Molecular Weight Heparin

Chapter 5. Global Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Heparin Market, by Route of Administration, 2016
5.2. Subcutaneous
5.3. Intravenous

Chapter 6. Global Heparin Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Heparin Market Analysis, 2015 – 2025
6.2.1. North America Heparin Market, by Product, 2015 – 2025 (US$ Mn)
6.2.2. North America Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
6.2.3. North America Heparin Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Heparin Market Analysis, 2015 – 2025
6.3.1. Europe Heparin Market, by Product, 2015 – 2025 (US$ Mn)
6.3.2. Europe Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
6.3.3. Europe Heparin Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Heparin Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Heparin Market, by Product, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Heparin Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. India
6.4.3.4. Rest of Asia Pacific
6.5. Latin America Heparin Market Analysis, 2015 – 2025
6.5.1. Latin America Heparin Market, by Product, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
6.5.3. Latin America Heparin Market, by Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Heparin Market Analysis, 2015 – 2025
6.6.1. Middle East and Africa Heparin Market, by Product, 2015 – 2025 (US$ Mn)
6.6.2. Middle East and Africa Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
6.6.3. Middle East and Africa Heparin Market, by Region, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of Middle East and Africa

Chapter 7. Company Profiles
7.1. Aspen Holdings
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Baxter International, Inc.
7.3. B. Braun Melsungen AG
7.4. Dr. Reddy’s Laboratories Ltd.
7.5. Fresenius SE & Co. KGaA
7.6. Leo Pharma A/S
7.7. Pfizer, Inc.
7.8. Sanofi AG
7.9. Syntex S.A.
7.10. Teva Pharmaceutical Industries Ltd.
..................toc continued

Full Report Originally published @ https://www.credenceresearch.com/report/heparin-market

List of Tables

TABLE 1 Global Heparin Market Portraiture
TABLE 2 Global Heparin Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 3 Global Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
TABLE 4 Global Heparin Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America Heparin Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 6 North America Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
TABLE 7 North America Heparin Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Heparin Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Heparin Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Asia Pacific Heparin Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 12 Asia Pacific Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Heparin Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 14 Latin America Heparin Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 15 Latin America Heparin Market, by Route of Administration, 2015 – 2025 (US$ Mn)

.........................continued

Full Report Originally published @ https://www.credenceresearch.com/report/heparin-market

Get Sample @ https://www.credenceresearch.com/sample-request/58943

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/heparin-market-2025-opportunities-illuminated-by-new-report-credence-research/479330

Source: MarketersMedia

Release ID: 479330